Patti Glaza

EVP & Managing Director @ Invest Detroit Ventures | MBA

📍 Detroit Metropolitan Area, United States🔄 Updated September 2026💼 5 investments📅 10 years investing🗓 Last invested Feb 2019𝕏 @upgrade_to_unlock
VC🌍 United States
5
Total investments
1
Early stage
4
Mid stage
0
Late stage
10y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Feb 2019
Ripple Science accelerates clinical research with its secure HIPAA-compliant suite of direct-to-participant engagement tools. Ripple is a software platform that helps our customers recruit more participants faster and reduces patients lost to follow-up. Ripple Science’s flagship product, Ripple SaaS, is currently being used by research investigators at more than 75 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.
Board Member
Nov 2018
Michigan-based Plinqit is an innovative fintech company serving fintechs, core providers, banks and credit unions across the country to easily and cost-effectively introduce new services for attracting and retaining customers. Plinqit is the first savings platform of its kind that pays users for engaging with content through its patented Build Skills™. For more information, visit www.info.plinqit.com.
Board Member
Oct 2018
Shoptelligence is a proven A.I.-powered style discovery platform that helps retailers increase revenue by offering an inspirational and engaging shopping experience. Backed by powerful algorithms and individualized customer style profiles we can accelerate your omnichannel retail strategy - growing ticket size and customer lifetime value.
mid stageRetail
Board Member
May 2017
Micro-LAM Technologies offers cutting edge technology through its state-of-the-art retrofitable system that is set to be a game changer in the advanced manufacturing industry. The hybrid laser-diamond cutting tool system provides profitable solutions for machining hard and brittle materials.
Board Member
Jan 2016
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and services. Genomenon offers advanced genomic software solutions designed to streamline and enhance genetic research and clinical decision-making. Our flagship product, the Mastermind® Genomic Intelligence Platform, provides comprehensive genomic data integration and analysis, offering researchers and clinicians a powerful tool to interpret genetic variants and their clinical relevance. Complementing this is the Cancer Knowledgebase (CKB), which focuses specifically on the landscape of somatic mutations, offering curated, actionable insights to support oncology research and personalized cancer treatment. Together, these platforms aim to accelerate discoveries and improve patient outcomes through sophisticated data analysis and knowledge integration.
Experience · 10 entries
All (10)
Investments (5)
Board (5)
2019
Board Member
Feb 2019
Ripple Science accelerates clinical research with its secure HIPAA-compliant suite of direct-to-participant engagement tools. Ripple is a software platform that helps our customers recruit more participants faster and reduces patients lost to follow-up. Ripple Science’s flagship product, Ripple SaaS, is currently being used by research investigators at more than 75 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.
2018
Board Member
Nov 2018
Michigan-based Plinqit is an innovative fintech company serving fintechs, core providers, banks and credit unions across the country to easily and cost-effectively introduce new services for attracting and retaining customers. Plinqit is the first savings platform of its kind that pays users for engaging with content through its patented Build Skills™. For more information, visit www.info.plinqit.com.
Board Member
Oct 2018
Shoptelligence is a proven A.I.-powered style discovery platform that helps retailers increase revenue by offering an inspirational and engaging shopping experience. Backed by powerful algorithms and individualized customer style profiles we can accelerate your omnichannel retail strategy - growing ticket size and customer lifetime value.
mid stageRetail
2017
Board Member
May 2017
Micro-LAM Technologies offers cutting edge technology through its state-of-the-art retrofitable system that is set to be a game changer in the advanced manufacturing industry. The hybrid laser-diamond cutting tool system provides profitable solutions for machining hard and brittle materials.
2016
Board Member
Jan 2016
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and services. Genomenon offers advanced genomic software solutions designed to streamline and enhance genetic research and clinical decision-making. Our flagship product, the Mastermind® Genomic Intelligence Platform, provides comprehensive genomic data integration and analysis, offering researchers and clinicians a powerful tool to interpret genetic variants and their clinical relevance. Complementing this is the Cancer Knowledgebase (CKB), which focuses specifically on the landscape of somatic mutations, offering curated, actionable insights to support oncology research and personalized cancer treatment. Together, these platforms aim to accelerate discoveries and improve patient outcomes through sophisticated data analysis and knowledge integration.
Show all 10 entries ↓
Investment activity
2016–2019 · 5 investments
20161201712018220191
Recent (last 2 years)Earlier